DK0572425T3 - Imidazopyridin-PAF/H1-antagonister - Google Patents

Imidazopyridin-PAF/H1-antagonister

Info

Publication number
DK0572425T3
DK0572425T3 DK92902889.2T DK92902889T DK0572425T3 DK 0572425 T3 DK0572425 T3 DK 0572425T3 DK 92902889 T DK92902889 T DK 92902889T DK 0572425 T3 DK0572425 T3 DK 0572425T3
Authority
DK
Denmark
Prior art keywords
pct
paf
antagonists
sec
imidazopyridine
Prior art date
Application number
DK92902889.2T
Other languages
Danish (da)
English (en)
Inventor
David Alker
Robert John Bass
Kelvin Cooper
Original Assignee
Pfizer
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Pfizer Ltd filed Critical Pfizer
Application granted granted Critical
Publication of DK0572425T3 publication Critical patent/DK0572425T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
DK92902889.2T 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-antagonister DK0572425T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
DK0572425T3 true DK0572425T3 (da) 1994-09-12

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92902889.2T DK0572425T3 (da) 1991-02-13 1992-01-24 Imidazopyridin-PAF/H1-antagonister

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
WO1996005201A1 (en) * 1994-08-10 1996-02-22 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
AU698487B2 (en) * 1995-08-05 1998-10-29 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
CA3050734A1 (en) 2003-05-15 2004-12-02 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
CN101932575B (zh) 2008-01-30 2013-06-12 日本脏器制药株式会社 哌啶衍生物
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US9296731B2 (en) * 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
CA2846394A1 (en) * 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
DE68920998T2 (de) * 1988-03-15 1995-06-22 Searle & Co 1H/3H-[4-(N,N-CYCLOALKYL UND/ODER VERZWEIGTES ALKYLCARBOXAMIDO)-BENZYL]IMDAZO[4,5-c]PYRIDINE ALS PAF-ANTAGONISTEN.
EP0339978B1 (en) * 1988-04-28 1996-08-21 Schering Corporation Fused polycyclic compounds, compositions, methods of manufacture, and their use as PAF antagonists, antihistamines and/or antiinflammatory agents
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
BR9106433A (pt) * 1990-05-09 1993-05-04 Pfizer Imidazo (4,5-c) piridinas com atividade antagonista ao paf

Also Published As

Publication number Publication date
JP2506541B2 (ja) 1996-06-12
GB9102997D0 (en) 1991-03-27
NO932889L (no) 1993-08-13
MX9200589A (es) 1992-10-01
JPH06504992A (ja) 1994-06-09
CS42592A3 (en) 1992-09-16
NO300592B1 (no) 1997-06-23
PL169304B1 (pl) 1996-06-28
AU1168392A (en) 1992-09-15
IE65125B1 (en) 1995-10-04
CZ280504B6 (cs) 1996-02-14
NO932889D0 (no) 1993-08-13
EG20085A (en) 1997-05-31
NZ241597A (en) 1993-04-28
IE920449A1 (en) 1992-08-12
TW227000B (enExample) 1994-07-21
BR9205615A (pt) 1994-05-17
YU14392A (sh) 1994-11-15
DE69200304T2 (de) 1994-12-08
ATE109482T1 (de) 1994-08-15
CA2099381C (en) 1996-07-09
DE69200304D1 (de) 1994-09-08
ZA921005B (en) 1993-08-12
HUT65947A (en) 1994-08-29
FI933531L (fi) 1993-08-10
WO1992014734A1 (en) 1992-09-03
YU48238B (sh) 1997-08-22
RU2114845C1 (ru) 1998-07-10
CA2099381A1 (en) 1992-08-14
EP0572425B1 (en) 1994-08-03
IL100887A (en) 1996-01-19
AU650322B2 (en) 1994-06-16
ES2059212T3 (es) 1994-11-01
FI933531A0 (fi) 1993-08-10
US5358953A (en) 1994-10-25
CN1040326C (zh) 1998-10-21
EP0572425A1 (en) 1993-12-08
HU211202A9 (en) 1995-11-28
HU9302327D0 (en) 1993-10-28
FI933531A7 (fi) 1993-08-10
MY108437A (en) 1996-09-30
KR970005302B1 (ko) 1997-04-15
CN1064275A (zh) 1992-09-09
IL100887A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
DE69200304D1 (de) Imidazopyridin-PAF/H1-Antagonisten.
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
YU157191A (sh) Antagonisti receptora fibrinogena
HRP950482B1 (en) SYNTHESIS OF 3-(4-(2-AMINOETOXY)BENZOYL)-ARYL-6-HYDROXYBENZO(b)THIOPHENE
HRP941000B9 (hr) Morfolin i tiomorfolin antagonisti receptora tahikinina
NO942758L (no) Benzopyraner og beslektede LTB4 antagonister
RU93054165A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция, способ лечения
CO4410319A1 (es) Derivados de fenetanolamina
FI922341A0 (fi) Piperidin- och pyrrolidinderivat.
MX9300312A (es) Antagonistas benzopiranicos y relacionado de ltb.
EA199800949A1 (ru) Антибактериальные соединения карбапенема, содержащие их фармацевтические композиции и способы лечения
SG164268A1 (en) Quinolin-4-yl derivatives i
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
ATE64373T1 (de) Muscarin-rezeptor-antagonisten.
YU4393A (sr) Supstituisani heksahidroazepinoni i tetrahidrobenzazepinoni
ES2095995T3 (es) Procedimiento para la obtencion de 2,2-difluorbenzo(1,3)dioxol-carbaldehidos y nuevos productos intermedios.
MX9606654A (es) Derivados de alaquildiamina substituida y su uso como antagonistas de taquicinina.
SE7609222L (sv) Alkylsulfonylaminosubstituerade heterocykler
DE69014903D1 (de) Disubstituierte piperidine und pyrrolidine als anticholinergische mittel.
MY102440A (en) Fungicidal pyridyl cyclopropane carboxamides.
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
DE3484375D1 (de) Pharmazeutische zusammenstellung fuer die prophylaxe oder behandlung von tierhaltungsketose.
ATE110367T1 (de) Kalziumantagonisten.
ES2084547B1 (es) Antagonistas benzopiranicos y relacionados de leucotrieno b4.
SE8301039D0 (sv) Heterocykliska derivat